Lamivudine; Zidovudine Patent Expiration
Lamivudine; Zidovudine is Used for the treatment of HIV. It was first introduced by Viiv Healthcare Co
Lamivudine; Zidovudine Patents
Given below is the list of patents protecting Lamivudine; Zidovudine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Combivir |
US5905082 (Pediatric) | Crystalline oxathiolane derivatives |
Nov 18, 2016
(Expired) | Viiv Hlthcare |
| Combivir | US5905082 | Crystalline oxathiolane derivatives |
May 18, 2016
(Expired) | Viiv Hlthcare |
| Combivir |
US5859021 (Pediatric) | Antiviral combinations |
Nov 15, 2012
(Expired) | Viiv Hlthcare |
Lamivudine; Zidovudine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List